Pricing Log in Create free account

Cuprina Holdings (Cayman) Limited (CUPR) vs Regentis Biomaterials Ltd. (RGNT)

Cuprina Holdings (Cayman) Limited and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Cuprina Holdings (Cayman) Limited and Regentis Biomaterials Ltd. are of similar size ($11.5M and $10.9M). Across the 4 metrics below, Cuprina Holdings (Cayman) Limited leads on 2 and Regentis Biomaterials Ltd. on 2.

Valuation

Metric CUPR RGNT Medical Instruments & Supplies median
P/E — — 33.75
P/S — — 2.52
P/B n/m n/m 2.48
Price to free cash flow — n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales n/m n/m 2.88
Earnings yield — — (2.67%)
Free cash flow yield — 0.00% 0.09%

Profitability

Metric CUPR RGNT Medical Instruments & Supplies median
Gross margin — — 54.29%
Operating margin — — 1.07%
Net margin — — (1.61%)
Free cash flow margin — 0.00% 1.08%
Return on equity — 0.00% (1.32%)
Return on assets — 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUPR RGNT Medical Instruments & Supplies median
Revenue growth (TTM) — — 8.85%
EPS growth (last fiscal year) (200.00%) (1,504.65%) 8.65%
Revenue growth, 5-year CAGR — — 9.17%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CUPR RGNT Medical Instruments & Supplies median
Debt to equity 0.07 0.00 0.10
Current ratio 2.35 5.62 2.48
Net debt to EBITDA 0.57 0.89 0.89

Dividend

Metric CUPR RGNT Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric CUPR RGNT Medical Instruments & Supplies median
Market cap 11.48m 10.89m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack